María de Lourdes Mora‐García

Author

Also Known As

M. L. Mora-García, M.L. Mora-García, Maria L. Mora-Garcia, Maria de Lourdes Mora-Garcia, María de L. Mora-García, María de L. Mora‐García, María de Lourdes Mora García, María de Lourdes Mora-García, María de Lourdes Mora‐García, María deLourdes Mora-García

Publications

716

Citations

H-Index

Concepts

All Affiliations

Mexican Social Security Institute Universidad Nacional Autónoma de México Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional Instituto Politécnico Nacional Instituto Nacional de Cancerología

About

María de Lourdes Mora‐García is an author at Mexican Social Security Institute specializing in medicine, immunology, and cervical cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	252
2	Cell Biology	6	6	153
3	Health Sciences	2	2	46
4	Natural Sciences	1	1	21
5	Public Health	1	1	29

María de Lourdes Mora‐García

Publications

635

Citations

H-Index

Page 1

	Year	Citations
Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid María de Lourdes Mora‐García, Alfonso Dueñas‐González, Jorge Hernández‐Montes, Journal of Translational Medicine	2006	73
Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions María de Lourdes Mora‐García, Rosario García‐Rocha, Omar Morales-Ramírez, Journal of Translational Medicine	2016	73
An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice Georgina Paz de la Rosa, Alberto Monroy, María de Lourdes Mora‐García, Virology Journal	2009	71
In Vitro Evidence of the Presence of Mesenchymal Stromal Cells in Cervical Cancer and Their Role in Protecting Cancer Cells from Cytotoxic T Cell Activity Juan José Montesinos, María de Lourdes Mora‐García, Héctor Mayani, Stem Cells and Development	2013	57
Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity Rosario García‐Rocha, Martha C. Moreno‐Lafont, María de Lourdes Mora‐García, Cytokine Cancer ImmunosurveillanceIl-10 ExpressionCervical CancerCervical Cancer TumorsMedicine	2015	41
Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model Alberto Monroy, Miguel Á. Gómez-Lim, Benny Weiss‐Steider, Archives of Virology VaccinationHpv-16 E6Human Papillomavirus VaccinesImmunologyAntiviral Response	2013	39
Human Papillomavirus Genotypes among Females in Mexico: a Study from the Mexican Institute for Social Security Mauricio Salcedo, Patricia Piña‐Sánchez, Verónica Vallejo‐Ruiz, Asian Pacific Journal of Cancer Prevention	2015	36
Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1 Rosario García‐Rocha, Alberto Monroy, Jorge Hernández‐Montes, Cytokine Cd73-adenosine PathwayCervical CancerMedicineCervical Cancer CellsCancer Cell Biology	2018	32
Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions Leticia Rocha‐Zavaleta, Juana P. Ambrosio, María de Lourdes Mora‐García, Journal of General Virology Viral DiagnosticsImmunologyPathologyGynecologyCytopathology	2004	29
Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway María de Lourdes Mora‐García, Luis Roberto Ávila-Ibarra, Rosario García‐Rocha, Cellular Immunology Cancer ImmunosurveillanceCytotoxic T CellsCervical CancerAdenosinergic PathwayImmunology	2017	24

Page 1